Compare Bond Review: Cloned-Firm Red Flags and High-Pressure Tactics
We brought Compare Bond onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: Compare Bond has drawn…